91983-31-2 Usage
Description
Methyl 5-bromo-2-hydroxy-3-nitrobenzenecarboxylate is a chemical compound with the molecular formula C8H6BrNO5. It is a white to light yellow solid that is commonly used in organic synthesis and pharmaceutical research. This versatile building block contains a bromine atom, a hydroxyl group, and a nitro group attached to a benzene ring, making it suitable for the synthesis of various organic compounds.
Uses
Used in Organic Synthesis:
Methyl 5-bromo-2-hydroxy-3-nitrobenzenecarboxylate is used as a reagent for the synthesis of various organic compounds due to its versatile reactivity and synthetic utility.
Used in Pharmaceutical Research:
Methyl 5-bromo-2-hydroxy-3-nitrobenzenecarboxylate is used as a building block in the preparation of pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemicals:
Methyl 5-bromo-2-hydroxy-3-nitrobenzenecarboxylate is used as a reagent in the synthesis of agrochemicals, aiding in the development of new pesticides and other agricultural chemicals.
Used in Chemical Research and Development:
Methyl 5-bromo-2-hydroxy-3-nitrobenzenecarboxylate is used as a valuable chemical in the field of chemical research and development, enabling the exploration of new chemical reactions and the creation of novel compounds.
Used in Fine Chemicals:
Methyl 5-bromo-2-hydroxy-3-nitrobenzenecarboxylate is used as a reagent in the production of fine chemicals, which are high-purity chemicals used in various industries such as pharmaceuticals, fragrances, and flavors.
Check Digit Verification of cas no
The CAS Registry Mumber 91983-31-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,9,8 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 91983-31:
(7*9)+(6*1)+(5*9)+(4*8)+(3*3)+(2*3)+(1*1)=162
162 % 10 = 2
So 91983-31-2 is a valid CAS Registry Number.
91983-31-2Relevant articles and documents
Novel aminopyrimidine EGFR inhibitor
-
Paragraph 3668-3673, (2021/03/24)
The present invention provides a novel aminopyrimidine compound that is a selective inhibitor of the fourth generation EGFR (T790M/C797S mutation), a pharmaceutical composition containing the compound, a useful intermediate for preparing the compound, and
DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY
-
Page/Page column 390; 391, (2019/11/12)
Provided herein are compounds of the Formula (I), (II), and (III), as well as pharmaceutically acceptable salts thereof, wherein the substituents are those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of oncologic diseases.
Benzoheterocycle-carboxamide-pyridone derivatives and preparation method and applications thereof
-
, (2018/03/26)
The invention belongs to the field of chemical medicine preparation, and concretely relates to benzoheterocycle-carboxamide-pyridone derivatives, a preparation method and applications thereof. The invention provides the benzoheterocycle-carboxamide-pyridone derivatives, and a structure is represented by a formula I. The present invention also provides the preparation method and the applications ofthe above benzoheterocycle-carboxamide-pyridone derivatives. The benzoheterocycle-carboxamide-pyridone derivatives provided by the invention are novel compounds obtained on the basis of a large number of screening, inhibit EZH2 activity, and provide a novel selection for development and application of medicines for resisting tumors and autoimmune diseases.
